Sign in

Wen Hsieh

Director at Amprius Technologies
Board

About Wen Hsieh

Independent Class I director of Amprius Technologies (AMPX), age 52 as of March 31, 2025, serving since September 2022; previously served on the Legacy Amprius board since December 2016. Co‑founded Matter Venture Partners in May 2023 (Founding Managing Partner); earlier, General Partner at Kleiner Perkins (Feb 2006–May 2023), with prior roles at McKinsey (Asia semiconductor practice) and founder of OnChip Technologies. Education: B.S., M.S., and Ph.D. in Electrical Engineering with a Biology Minor from Caltech; recognized for strategy, finance, and scientific expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kleiner Perkins Caufield & ByersGeneral Partner (hardware-focused)Feb 2006–May 2023 Venture investing leadership; hardware domain expertise
McKinsey & Company (San Francisco)Associate Principal; leader, Asia semiconductor practice— (prior to 2006) Led engagements across global semiconductor value chain
OnChip TechnologiesFounderMEMS microfluidic biochips; startup leadership

External Roles

OrganizationRoleStatus/Notes
Desktop Metal, Inc.DirectorCurrent public company directorship
Movella Holdings, Inc.DirectorCurrent public company directorship
AEye, Inc.DirectorPrior public company board service
Various private companiesDirectorMultiple privately held company boards

Board Governance

  • Independence: Board affirmatively determined Dr. Hsieh is independent under NYSE rules (audit, compensation, and nominating committees require independence) .
  • Committee assignments: Audit Committee member; Compensation Committee Chair. 2025 committees: Audit (Bayless, Dixon, Hsieh; Bayless Chair) and Compensation (Hsieh Chair; Dixon; Satterthwaite) .
  • Attendance: In 2024, the board held nine meetings; each director except Dr. Chu attended at least 75% of board and committee meetings (indicates Hsieh ≥75% attendance). In 2023, all directors attended at least 75% .
  • Executive sessions: Corporate governance guidelines provide for periodic executive sessions of non‑employee and independent directors .
  • Board tenure: Class I director; current term expires 2026 .

Fixed Compensation

Metric202220232024
Fees Earned or Paid in Cash ($)$19,076 $65,000 $65,000
Stock Awards ($)$170,003 $170,000
Option Awards ($)$417,849
Total ($)$436,925 $235,003 $235,000

Director compensation policy (cash retainers):

  • $40,000 annual director retainer; $15,000 Compensation Committee Chair; $10,000 Audit Committee member; plus other chair/member fees as applicable .
  • Annual director equity RSU grant with $170,000 grant‑date value; initial RSU grant $300,000 for new non‑employee directors; vesting is time‑based; director awards accelerate fully upon change‑in‑control .

Outstanding director equity awards (year‑end):

MetricDec 31, 2023Dec 31, 2024
Aggregate Number of Shares Underlying Outstanding Options270,251 270,251
Aggregate Number of Shares Underlying Stock Awards (RSUs)17,895 125,000

Performance Compensation

  • No performance‑based director compensation disclosed; director equity is time‑based RSUs under the Outside Director Compensation Policy; no director performance metrics tied to compensation are disclosed .

Other Directorships & Interlocks

  • Current public boards: Desktop Metal, Movella; prior AEye; multiple private boards .
  • No related‑party transactions disclosed involving Wen Hsieh; audit committee oversees related‑party transactions under a written policy .
  • PIPE participation and sponsor‑related transactions noted for other directors; none cite Hsieh .

Expertise & Qualifications

  • Venture investing leadership (Kleiner Perkins, Matter Venture Partners); hardware domain and technology commercialization .
  • Strategic consulting (semiconductors) and operational insight across global value chains .
  • Deep technical credentials (Caltech Ph.D.; EE with Biology Minor), relevant to battery and advanced materials ecosystems .

Equity Ownership

MetricMar 31, 2024Mar 31, 2025
Total Shares Beneficially Owned157,646 (options exercisable within 60 days) 243,104
Ownership % of Shares Outstanding<1% <1%
Common Shares— (not disclosed) 17,895
Options Exercisable Within 60 Days157,646 225,209
  • Section 16(a) compliance: Company reported no delinquent filings in 2025; in 2024, one late Form 4 for an executive (Dr. Stefan), not Hsieh .
  • Hedging/pledging: Directors prohibited from short sales, derivatives, hedging transactions, pledging, and margin accounts per Insider Trading Policy .

Compensation Committee Analysis

  • Composition and leadership: Hsieh (Chair) with independent directors (2025: Dixon, Satterthwaite; 2024: Dixon, Gustanski). All members satisfy SEC/NYSE independence standards; non‑employee directors under Rule 16b‑3 .
  • Consultant: Compensia retained to advise on executive compensation and peers; committee assessed consultant independence; no conflicts reported .
  • Activity: Compensation committee held five meetings in 2024; oversees executive incentive plans, non‑employee director pay, equity plan administration, and disclosure .

Governance Assessment

  • Strengths

    • Independence and committee leadership (Compensation Chair; Audit member) support robust oversight of pay and financial controls .
    • Adequate attendance (≥75% in 2024; all directors ≥75% in 2023) and active committee engagement .
    • No disclosed related‑party transactions involving Hsieh; prohibitions on hedging/pledging enhance alignment .
    • Director equity is time‑based with change‑in‑control acceleration typical for market; predictable pay structure (cash + RSUs) .
  • Watch items

    • Shift from options (2022) to RSUs (2023–2024) reduces at‑risk leverage vs. options; monitor equity mix trend and any future modifications .
    • Change‑in‑control full acceleration for director awards is standard but can be viewed as entrenchment risk; consider overall board practices and investor preferences .
  • Overall: Governance signals (independence, committee leadership, attendance, lack of related‑party exposure) are supportive of investor confidence in board effectiveness, with pay structure consistent with small‑cap norms .